SUBA-Itraconazole: Phase IIb started

HedgePath began the open-label, U.S. Phase IIb SCORING trial to evaluate 100 mg oral SUBA-Itraconazole twice

Read the full 167 word article

How to gain access

Continue reading with a
two-week free trial.